Creating Value for Life Science Research!

Get a Free Sample of this product!
shopping cart image

Anti-Human sTRAIL/Apo2L

Catalog Number : 500-M49


Produced in BALB/c x ICR F1 mice using highly pure (>98%) recombinant human TRAIL/APO2L as the immunizing antigen. This IgG1K antibody was purified from ascites fluid by Protein A affinity chromatography.

Additional Information

Recombinant Human sTRAIL/Apo2L (BioGems Catalog #310-04)
Monoclonal Mouse
This antibody stained formalin-fixed, paraffin-embedded sections of human renal cell carcinoma.  The recommended concentration is 2.5 µg/mL- 1.5 µg/mL with an overnight incubation at 4˚C.  An HRP-labeled polymer detection system was used with a DAB chromogen.  Heat induced antigen retrieval with a pH 9.0 buffer is recommended.  Optimal concentrations and conditions may vary.   

Tissue samples were provided by the Cooperative Human Tissue Network, which is funded by the National Cancer Institute. 
Information and photo are courtesy of Flagship Biosciences, LLC – Histology Services.
To yield one-half maximal inhibition [ND50] of the biological activity of Human TRAIL/Apo2L (10.0 ng/ml), a concentration of 0.30-0.60 μg/ml of this antibody is required.
Sandwich ELISA:
In a sandwich ELISA (assuming 100µl/well), a concentration of 2.0-4.0 µg/ml of this antibody will detect at least 500 pg/ml of recombinant human sTRAIL/APO2L when used with BioGems' biotinylated antigen affinity purified anti-human sTRAIL/APO2L (60-330BT) as the detection antibody at a concentration of approximately 1.0-2.0 µg/ml.
Western Blot:
To detect Human sTRAIL/Apo2L by Western Blot analysis this antibody can be used at a concentration of 0.25-0.50 µg/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human sTRAIL/Apo2L is 0.25-1.0 ng/lane, under reducing or non-reducing conditions.

Availability: In stock

Size Price Qty